The COVID-19 (coronavirus disease-2019) pandemic has presented unprecedented challenges to regulatory organizations, the biotech and pharmaceutical industry, and the publishing industry. This Translational Perspectives paper attempts to highlight some of the challenges and perils of moving extraordinarily fast in an effort to save human lives in the midst of a global pandemic. As with the development of all new therapeutic approaches, it will take time to assess the risks and benefits of developing new therapies at "warp speed".
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393415 | PMC |
| http://dx.doi.org/10.1016/j.jacbts.2020.06.001 | DOI Listing |
Publication Analysis
Top Keywords
"warp speed"
8
speed" operations
4
operations covid-19
4
covid-19 pandemic
4
pandemic moving
4
moving quickly?
4
quickly? covid-19
4
covid-19 coronavirus
4
coronavirus disease-2019
4
disease-2019 pandemic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!